Biotech · Private company
Stemedica Cell Technologies, Inc.
Track this companyFree. Adds Stemedica Cell Technologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Allogeneic Mesenchymal Bone Marrow CellsPhase 2 · Chronic Effect of Ultraviolet Radiation on Photoaged SkinClinicalTrials.gov · fetched Nov 12, 2026
- hMSCPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- Human Mesenchymal Stem Cells and Lactated Riunger's SolutionPhase 2 · Alzheimer DementiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19PHASE2 · UNKNOWN · started Mar 20, 2021ClinicalTrials.gov NCT04780685 · fetched Nov 12, 2026
- Allogeneic Human Mesenchymal Stem Cells for Alzheimer's DiseasePHASE2 · UNKNOWN · started Jun 1, 2016ClinicalTrials.gov NCT02833792 · fetched Nov 12, 2026
- Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous PhotoagingPHASE1_PHASE2 · UNKNOWN · started Jul 1, 2015ClinicalTrials.gov NCT01771679 · fetched Nov 12, 2026
- A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart FailurePHASE2 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02467387 · fetched Nov 12, 2026